The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice

[21] Garcha HS(2008) receptor Neuropharmacology 54 1189-1200

[22] Stolerman IP(1998)Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors Nature 391 173-177

[23] Grady SR(2007)Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras Neuropharmacology 52 985-994

[24] Drenan RM(2007)Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine Trends Pharmacol Sci 28 316-325

[25] Breining SR(2002)Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid Neuropharmacology 42 530-539

[26] Yohannes D(2007)Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation Psychopharmacology 190 157-170

[27] Wageman CR(1997)The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion Psychopharmacology 129 390-397

[28] Fedorov NB(1999)Ligands selective for α4β2 but not α3β4 or α7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat Psychopharmacology 141 297-306

[29] McKinney S(2004)Selective antagonism of behavioural effects of nicotine by dihydro-β-erythroidine in rats Neuropharmacology 46 363-371

[30] Whiteaker P(1990)Discrimination and self-administration of nicotine by inbred strains of mice FEBS Lett 270 45-48

[21] Garcha HS(2008) receptor Neuropharmacology 54 1189-1200

[22] Stolerman IP(1998)Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors Nature 391 173-177

[23] Grady SR(2007)Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras Neuropharmacology 52 985-994

[24] Drenan RM(2007)Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine Trends Pharmacol Sci 28 316-325

[25] Breining SR(2002)Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid Neuropharmacology 42 530-539

[26] Yohannes D(2007)Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation Psychopharmacology 190 157-170

[27] Wageman CR(1997)The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion Psychopharmacology 129 390-397

[28] Fedorov NB(1999)Ligands selective for α4β2 but not α3β4 or α7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat Psychopharmacology 141 297-306

[29] McKinney S(2004)Selective antagonism of behavioural effects of nicotine by dihydro-β-erythroidine in rats Neuropharmacology 46 363-371

[30] Whiteaker P(1990)Discrimination and self-administration of nicotine by inbred strains of mice FEBS Lett 270 45-48